Search results

Selected filters:

Patent Pools
Analysis

Article type

Topic

Sector

Regions

Year

47 results found for your search

Sort options
13 May 2019

Continental lawsuit against Avanci could help set the terms for licensing in the IoT 

Key automotive supplier accuses pool operator, Nokia and several other patent owners of antitrust violations in what looks set to become a blockbuster case in front of the Northern California federal district court

09 May 2019

Spirit of collaboration in the air at IAM’s fourth Auto IP USA event

With the industry facing numerous competitive challenges, traditional operators are increasingly turning to partnerships with new and existing players in a dynamic that throws up numerous IP challenges  

02 May 2019

Avanci’s success suggests that patent pools have a bright future. If only the HEVC community would get the message

News that five more Volkswagen brands have signed up to the IoT platform underline strengths of a pooled approach in providing transparency and certainty to SEP licensing

15 April 2019

Five key takeaways from Avanci's breakthrough licensing deals with Audi and Porsche

From the importance of bringing Nokia on board to the prospects of an agreement with one of the major American or Japanese manufacturers, we tell you what you need to know about the news of the platform's German transactions

12 April 2019

Via Licensing signals China focus with new deals and big hires

In an interview with IAM, firm president Joe Siino (pictured, far right) also confirms expansion of operations in Hong Kong, with former Technicolor licensing head Deirdre Leane soon to join the team

26 March 2019

Top state life sciences R&D deal-maker explains how to overcome patent barriers to partnerships

A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them

25 March 2019

Broadcom’s lawsuits against the auto industry escalate, but other patent owners stay out of court

Filings against Daimler and BMW follow court actions against Toyota and VW - and it could only be a matter of time before others start to get more assertive

07 March 2019

More technology transfer needed for effective climate change mitigation  

Patent focus has shifted to energy storage as cost-effectiveness achieved for wind and solar power, but the failure to address the role of IP hinders transfer mechanisms    

26 February 2019

SEP licence with Sisvel creates template for deal that could end up saving industry billions of dollars, says RPX CEO 

Dan McCurdy (left) and Mattia Fogliacco (right) open up about the ground-breaking patent agreement their two firms secured in January - and explain why it is potentially so important

15 February 2019

PanOptis acquired by New York-based private equity business

The NPE, which bought Unwired Planet in 2016 and owns thousands of patents previously held by Ericsson and Panasonic, sold to Brevet Capital for an undisclosed sum

28 January 2019

New industry forum seeks to bridge licensor/licensee divide and chart a new course for next video codec

Apple, Canon, Dolby, Ericsson and InterDigital are among early backers of attempt to change the licensing dynamic for the VVC standard

14 January 2019

Pool operator questions "fatally flawed" Unified Patents study on HEVC royalty rates

Research was released as a new industry forum met in Silicon Valley to discuss the potential of a different approach to licensing the next video codec standard

04 January 2019

All the major China IP stories you missed over the holidays

Retrial ordered in Huawei v InterDigital; Apple representatives threatened with detention in continuing injunction flap; national IP appeals court opens doors and much more from the Middle Kingdom

23 November 2018

Xiaomi inks video licence as Huawei loses German court case

Sources tell IAM MPEG-LA has secured an AVC/H.264 licence with Xiaomi. 

02 November 2018

Four patent lessons the tech sector can teach life sciences companies

With biopharma businesses facing up to unprecedented technological change, the IP issues that they deal with may begin to look more like those that have already become common elsewhere